Molecular biomarkers have the potential to improve the diagnostic work-up of pancreatic cystic lesions

References

• Fernandez-del Castillo C, Targarona J, Thayer SP, et al. Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg. 2003;138:427–423. discussion 33–34.
   PubMed Web of Science ®Google Scholar
• Gaujoux S, Brennan MF, Gonen M, et al. Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period. J Am Coll Surg. 2011;212:590–600. discussion 3.
   PubMed Web of Science ®Google Scholar
• Wu BU, Sampath K, Berberian CE, et al. Prediction of malignancy in cystic neoplasms of the pancreas: a population-based cohort study. Am J Gastroenterol. 2014;109:121–129. quiz 30.
   PubMed Web of Science ®Google Scholar
• Dudeja V, Allen PJ. Premalignant cystic neoplasms of the pancreas. Semin Oncol. 2015;42:70–85.
   PubMed Web of Science ®Google Scholar
• Compagno J, Oertel JE. Microcystic adenomas of the pancreas (glycogen-rich cystadenomas): a clinicopathologic study of 34 cases. Am J Clin Pathol. 1978;69:289–298.
   PubMed Web of Science ®Google Scholar
• Strobel O, Z'Graggen K, Schmitz-Winnenthal FH, et al. Risk of malignancy in serous cystic neoplasms of the pancreas. Digestion. 2003;68:24–33.
   PubMed Web of Science ®Google Scholar
• Cho CS, Russ AJ, Loeffler AG, et al. Preoperative classification of pancreatic cystic neoplasms: the clinical significance of diagnostic inaccuracy. Ann Surg Oncol. 2013;20:3112–3119.
   PubMed Web of Science ®Google Scholar
• Lewis GH, Wang H, Bellizzi AM, et al. Prognosis of minimally invasive carcinoma arising in mucinous cystic neoplasms of the pancreas. Am J Surg Pathol. 2013;37:601–605.
   PubMed Web of Science ®Google Scholar
• Al-Haddad M, DeWitt J, Sherman S, et al. Performance characteristics of molecular (DNA) analysis for the diagnosis of mucinous pancreatic cysts. Gastrointest Endosc. 2014;79:79–87.
   PubMed Web of Science ®Google Scholar
• Maitra A, Fukushima N, Takaori K, et al. Precursors to invasive pancreatic cancer. Adv Anat Pathol. 2005;12:81–91.
   PubMed Web of Science ®Google Scholar
• Hruban RH, Takaori K, Canto M, et al. Clinical importance of precursor lesions in the pancreas. J Hepatobiliary Pancreat Surg. 2007;14:255–263.
   PubMedGoogle Scholar
• Sidden CR, Mortele KJ. Cystic tumors of the pancreas: ultrasound, computed tomography, and magnetic resonance imaging features. Semin Ultrasound CT MR. 2007;28:339–356.
   PubMed Web of Science ®Google Scholar
• Nougaret S, Mannelli L, Pierredon MA, et al. Cystic pancreatic lesions: from increased diagnosis rate to new dilemmas. Diagn Interv Imaging. 2016;97:1275–1285.
   PubMed Web of Science ®Google Scholar
• Chu LC, Singhi AD, Haroun RR, et al. The many faces of pancreatic serous cystadenoma: radiologic and pathologic correlation. Diagn Interv Imaging. 2017;98:191–202.
   PubMed Web of Science ®Google Scholar
• Pozzessere C, Castanos Gutierrez SL, Corona-Villalobos CP, et al. Diffusion-weighted magnetic resonance imaging in distinguishing between mucin-producing and serous pancreatic cysts. J Comput Assist Tomogr. 2016;40:505–512.
   PubMed Web of Science ®Google Scholar
• Barral M, Taouli B, Guiu B, et al. Diffusion-weighted MR imaging of the pancreas: current status and recommendations. Radiology. 2015;274:45–63.
   PubMed Web of Science ®Google Scholar
• Nikiforova MN, Khalid A, Fasanella KE, et al. Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts. Mod Pathol. 2013;26:1478–1487.
   PubMed Web of Science ®Google Scholar
• Brugge WR, Lewandrowski K, Lee-Lewandrowski E, et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology. 2004;126:1330–1336.
   PubMed Web of Science ®Google Scholar
• Rogart JN, Loren DE, Singu BS, et al. Cyst wall puncture and aspiration during EUS-guided fine needle aspiration may increase the diagnostic yield of mucinous cysts of the pancreas. J Clin Gastroenterol. 2011;45:164–169.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Fernandez-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183–197.
   PubMed Web of Science ®Google Scholar
• Han DH, Lee H, Park JY, et al. Validation of international consensus guideline 2012 for intraductal papillary mucinous neoplasm of pancreas. Ann Surg Treat Res. 2016;90:124–130.
   PubMed Web of Science ®Google Scholar
• Nguyen AH, Toste PA, Farrell JJ, et al. Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer. J Gastrointest Surg. 2015;19:258–265.
   PubMed Web of Science ®Google Scholar
• Sahora K, Mino-Kenudson M, Brugge W, et al. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series. Ann Surg. 2013;258:466–475.
   PubMed Web of Science ®Google Scholar
• Al-Haddad MA, Kowalski T, Siddiqui A, et al. Integrated molecular pathology accurately determines the malignant potential of pancreatic cysts. Endoscopy. 2015;47:136–142.
   PubMed Web of Science ®Google Scholar
• Izeradjene K, Combs C, Best M, et al. Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. Cancer Cell. 2007;11:229–243.
   PubMed Web of Science ®Google Scholar
• Jimenez RE, Warshaw AL, Z'Graggen K, et al. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy. Ann Surg. 1999;230:501–509. discussion 9–11.
   PubMed Web of Science ®Google Scholar
• Kim SG, Wu TT, Lee JH, et al. Comparison of epigenetic and genetic alterations in mucinous cystic neoplasm and serous microcystic adenoma of pancreas. Mod Pathol. 2003;16:1086–1094.
   PubMed Web of Science ®Google Scholar
• Hong SM, Omura N, Vincent A, et al. Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res. 2012;18:700–712.
   PubMed Web of Science ®Google Scholar
• Biankin AV, Biankin SA, Kench JG, et al. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma. Gut. 2002;50:861–868.
   PubMed Web of Science ®Google Scholar
• Fukushima N, Fukayama M. Mucinous cystic neoplasms of the pancreas: pathology and molecular genetics. J Hepatobiliary Pancreat Surg. 2007;14:238–242.
   PubMedGoogle Scholar
• Blackford A, Serrano OK, Wolfgang CL, et al. SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer. Clin Cancer Res. 2009;15:4674–4679.
   PubMed Web of Science ®Google Scholar
• Kuboki Y, Shimizu K, Hatori T, et al. Molecular biomarkers for progression of intraductal papillary mucinous neoplasm of the pancreas. Pancreas. 2015;44:227–235.
   PubMed Web of Science ®Google Scholar
• Schonleben F, Allendorf JD, Qiu W, et al. Mutational analyses of multiple oncogenic pathways in intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2008;36:168–172.
   PubMed Web of Science ®Google Scholar
• Kitago M, Ueda M, Aiura K, et al. Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas. Int J Cancer. 2004;110:177–182.
   PubMed Web of Science ®Google Scholar
• Lohr M, Maisonneuve P, Lowenfels AB. K-Ras mutations and benign pancreatic disease. Int J Pancreatol. 2000;27:93–103.
   PubMedGoogle Scholar
• Amato E, Molin MD, Mafficini A, et al. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. J Pathol. 2014;233:217–227.
   PubMed Web of Science ®Google Scholar
• Shi C, Hruban RH. Intraductal papillary mucinous neoplasm. Hum Pathol. 2012;43:1–16.
   PubMed Web of Science ®Google Scholar
• Kanda M, Sadakari Y, Borges M, et al. Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia. Clin Gastroenterol Hepatol. 2013;11:719–730.e5.
   PubMed Web of Science ®Google Scholar
• Sasaki S, Yamamoto H, Kaneto H, et al. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas. Oncol Rep. 2003;10:21–25.
   PubMed Web of Science ®Google Scholar
• Wu J, Matthaei H, Maitra A, et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med. 2011;3:92ra66.
   PubMed Web of Science ®Google Scholar
• Matthaei H, Wu J, Dal Molin M, et al. GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as “incipient IPMNs”. Am J Surg Pathol. 2014;38:360–363.
   PubMed Web of Science ®Google Scholar
• Wu J, Jiao Y, Dal Molin M, et al. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci USA. 2011;108:21188–21193.
   PubMed Web of Science ®Google Scholar
• Furukawa T, Kuboki Y, Tanji E, et al. Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep. 2011;1:161.
   PubMed Web of Science ®Google Scholar
• Singhi AD, Nikiforova MN, Fasanella KE, et al. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts. Clin Cancer Res. 2014;20:4381–4389.
   PubMed Web of Science ®Google Scholar
• Kanda M, Knight S, Topazian M, et al. Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut. 2013;62:1024–1033.
   PubMed Web of Science ®Google Scholar
• Takano S, Fukasawa M, Maekawa S, et al. Deep sequencing of cancer-related genes revealed GNAS mutations to be associated with intraductal papillary mucinous neoplasms and its main pancreatic duct dilation. PLoS One. 2014;9:e98718.
   PubMed Web of Science ®Google Scholar
• Karakas B, Bachman KE, Park BH. Mutation of the PIK3CA oncogene in human cancers. Br J Cancer. 2006;94:455–459.
   PubMed Web of Science ®Google Scholar
• Samuels Y, Wang Z, Bardelli A, et al. High frequency of mutations of the PIK3CA gene in human cancers. Science. 2004;304:554.
   PubMed Web of Science ®Google Scholar
• Schonleben F, Qiu W, Ciau NT, et al. PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas. Clin Cancer Res. 2006;12:3851–3855.
   PubMed Web of Science ®Google Scholar
• Garcia-Carracedo D, Chen ZM, Qiu W, et al. PIK3CA mutations in mucinous cystic neoplasms of the pancreas. Pancreas. 2014;43:245–249.
   PubMed Web of Science ®Google Scholar
• Thosani N, Dasari CS, Bhutani MS, et al. Molecular pathogenesis of intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2010;39:1129–1133.
   PubMed Web of Science ®Google Scholar
• Iacobuzio-Donahue CA, Klimstra DS, Adsay NV, et al. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. Am J Pathol. 2000;157:755–761.
   PubMed Web of Science ®Google Scholar
• Chang TC, Mendell JT. microRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet. 2007;8:215–239.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang KY, Liu SM, et al. Tumor-associated circulating microRNAs as biomarkers of cancer. Molecules. 2014;19:1912–1938.
   PubMed Web of Science ®Google Scholar
• Wang J, Paris PL, Chen J, et al. Next generation sequencing of pancreatic cyst fluid microRNAs from low grade-benign and high grade-invasive lesions. Cancer Lett. 2015;356:404–409.
   PubMed Web of Science ®Google Scholar
• Ryu JK, Matthaei H, Dal Molin M, et al. Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma. Pancreatology. 2011;11:343–350.
   PubMed Web of Science ®Google Scholar
• Farrell JJ, Toste P, Wu N, et al. Endoscopically acquired pancreatic cyst fluid microRNA 21 and 221 are associated with invasive cancer. Am J Gastroenterol. 2013;108:1352–1359.
   PubMed Web of Science ®Google Scholar
• Habbe N, Koorstra JB, Mendell JT, et al. MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther. 2009;8:340–346.
   PubMed Web of Science ®Google Scholar
• Caponi S, Funel N, Frampton AE, et al. The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms. Ann Oncol. 2013;24:734–741.
   PubMed Web of Science ®Google Scholar
• Matthaei H, Wylie D, Lloyd MB, et al. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res. 2012;18:4713–4724.
   PubMed Web of Science ®Google Scholar
• He H, Di Y, Liang M, et al. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer. Oncol Rep. 2013;30:651–658.
   PubMed Web of Science ®Google Scholar
• Li A, Yu J, Kim H, et al. MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls. Clin Cancer Res. 2013;19:3600–3610.
   PubMed Web of Science ®Google Scholar
• Yu J, Li A, Hong SM, et al. MicroRNA alterations of pancreatic intraepithelial neoplasias. Clin Cancer Res. 2012;18:981–992.
   PubMed Web of Science ®Google Scholar
• Springer S, Wang Y, Dal Molin M, et al. A combination of molecular markers and clinical features improve the classification of pancreatic cysts. Gastroenterology. 2015;149:1501–1510.
   PubMed Web of Science ®Google Scholar
• Kwon RS, Simeone DM. The use of protein-based biomarkers for the diagnosis of cystic tumors of the pancreas. Int J Proteomics. 2011;2011:413646.
   PubMedGoogle Scholar
• Del Chiaro M, Segersvard R, Pozzi Mucelli R, et al. Comparison of preoperative conference-based diagnosis with histology of cystic tumors of the pancreas. Ann Surg Oncol. 2014;21:1539–1544.
   PubMed Web of Science ®Google Scholar
• Matthaei H, Feldmann G, Lingohr P, et al. Molecular diagnostics of pancreatic cysts. Langenbecks Arch Surg. 2013;398:1021–1027.
   PubMed Web of Science ®Google Scholar
• Jones M, Zheng Z, Wang J, et al. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts. Gastrointest Endosc. 2016;83:140–148.
   PubMed Web of Science ®Google Scholar
• Khalid A, Zahid M, Finkelstein SD, et al. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointestinal Endosc. 2009;69:1095–1102.
   PubMed Web of Science ®Google Scholar
• Wang Q, Chaerkady R, Wu J, et al. Mutant proteins as cancer-specific biomarkers. Proc Natl Acad Sci USA. 2011;108:2444–2449.
   PubMed Web of Science ®Google Scholar
• Earl J, Garcia-Nieto S, Martinez-Avila JC, et al. Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer. BMC Cancer. 2015;15:797.
   PubMed Web of Science ®Google Scholar
• Takai E, Totoki Y, Nakamura H, et al. Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer. Sci Rep. 2015;5:18425.
   PubMed Web of Science ®Google Scholar
• Allenson K, Castillo J, San Lucas FA, et al. High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients. Ann Oncol. 2017;28:741–747.
   PubMed Web of Science ®Google Scholar
• Konda VJ, Meining A, Jamil LH, et al. A pilot study of in vivo identification of pancreatic cystic neoplasms with needle-based confocal laser endomicroscopy under endosonographic guidance. Endoscopy. 2013;45:1006–1013.
   PubMed Web of Science ®Google Scholar
• Napoleon B, Lemaistre AI, Pujol B, et al. In vivo characterization of pancreatic cystic lesions by needle-based confocal laser endomicroscopy (nCLE): proposition of a comprehensive nCLE classification confirmed by an external retrospective evaluation. Surg Endosc. 2016.
   Web of Science ®Google Scholar
• Nakai Y, Iwashita T, Park do H, et al. Diagnosis of pancreatic cysts: EUS-guided, through-the-needle confocal laser-induced endomicroscopy and cystoscopy trial: DETECT study. Gastrointest Endosc. 2015;81:1204–1214.
   PubMed Web of Science ®Google Scholar
• Bhutani MS, Koduru P, Joshi V, et al. EUS-guided needle-based confocal laser endomicroscopy: a novel technique with emerging applications. Gastroenterol Hepatol (NY). 2015;11:235–240.
   PubMedGoogle Scholar
• Karia K, Waxman I, Konda VJ, et al. Needle-based confocal endomicroscopy for pancreatic cysts: the current agreement in interpretation. Gastrointest Endosc. 2016;83:924–927.
   PubMed Web of Science ®Google Scholar
• Shakhatreh MH, Naini SR, Brijbassie AA, et al. Use of a novel through-the-needle biopsy forceps in endoscopic ultrasound. Endosc Int Open. 2016;4:E439–E442.
   PubMed Web of Science ®Google Scholar
• Samarasena JB, Nakai Y, Shinoura S, et al. EUS-guided, through-the-needle forceps biopsy: a novel tissue acquisition technique. Gastrointest Endosc. 2015;81:225–226.
   PubMed Web of Science ®Google Scholar